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The Nef gene of the human and simian immunodeficiency viruses HIV and SIV has been implicated in pathogenicity;
however, the mechanism by which Nef induces disease is still unknown. An impact on signal transduction in cells has been
suggested by the interaction of Nef from an HIV-1 strain and tyrosine kinases like HCK and LCK as well as serine/threonine
kinases. We have confirmed the binding of HCK to HIV-1 subtype B Nef and demonstrated an equally strong interaction with
a subtype E Nef protein but weaker binding to Nef of HIV-2 subtype A (HIV-2D194). No binding, however, was observed to HIV-2
subtype B Nef (HIV-2D205). Instead, this protein bound to a novel cellular protein, Nefin1, with characteristics of an adaptor
protein and strong expression in all human hematopoietic tissues. Nefin1 binds through an amino-terminal domain, which is
related to SH3 domains. For interaction of Nef with Nefin1, the PxxP motif and the three-dimensional conformation of the
molecule appear necessary. In conclusion, this study demonstrates that Nef proteins of divergent strains of HIV-1 and HIV-2
may use different elements of signal transduction pathways for the induction of pathogenicity in vivo. © 1998 Academic Press
INTRODUCTION
Nef is one of the early genes of HIV and SIV. Nef
deletion mutants of SIVmac239 show poor replication in
vivo and AIDS-like symptoms do not evolve in adult
animals (Kestler et al., 1991). For HIV, a reduced patho-
genicity of deletion mutants has also been shown (Dea-
con et al., 1995; Kirchhoff et al., 1995). However, the
molecular mechanisms by which nef induces pathoge-
nicity are still unclear.
In cell culture, different effects of Nef have been de-
scribed (for review see Trono, 1995). Downregulation of
CD4 from the cell membrane is dependent on an acidic
stretch of amino acids in the amino-terminal region of
Nef. This motif is conserved between the Nef proteins of
different HIV and SIV strains and the effect seems to be
mediated by interaction with a dileucine motif in the
carboxy-terminal tail of CD4 (Salghetti et al., 1995). How-
ever, the activity of different Nef alleles varies consider-
ably (Mariani and Skowronski, 1993; Michael et al., 1995).
In addition to CD4 downregulation an increased infectiv-
ity of virions produced from cells in which Nef is present
was observed. However, the magnitude of the effect on
infectivity varies and may correlate to the activation state
of the target cell (Miller et al., 1994, 1995; Chowers et al.,
1994; Aiken and Trono, 1995; Schwartz et al., 1995). This
effect is dependent on a proline-rich region in Nef (Gold-
smith et al., 1995; Saksela et al., 1995), which is also
conserved between different isolates and resembles an
SH3 domain binding site. The SH3 domain of the human
protein tyrosine kinase HCK interacts with this domain of
HIV-1NL4-3 Nef in vitro (Saksela et al., 1995). The associ-
ation of the proline-rich region of Nef with HCK was
shown to promote an increase of the activity of HCK
(Moarefi et al., 1997), which results from a displacement
of the newly identified intramolecular interaction of the
SH3 domain of HCK with the SH2-kinase linker region
(Sicheri et al., 1997).
HIV-2D205 is a highly divergent HIV-2 isolate (Dietrich
et al., 1989) and was the first identified member of the
HIV-2 subtype B family, which is not as widespread as
the more common HIV-2 subtype A. Because of the
genetic divergence even in the SH3 binding motif of this
isolate, we investigated the binding properties of
HIV-2D205 in comparison to more common strains of
HIV-2 and different subtypes of HIV-1. While the interac-
tion of Nef from HIV-1LAI with HCK could be confirmed in
a two-hybrid system and an HIV-1 subtype E isolate
showed equally strong binding, HIV-2D205 Nef did not
bind to HCK and HIV-2D194 Nef (an HIV-2 subtype A
isolate with high replication capacity in macrophages,
Ku¨hnel et al., 1989) bound only weakly. In addition, a
novel Nef interaction partner, Nefin1, with characteristics
of an adaptor protein, was isolated. This protein inter-
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acted specifically with HIV-2D205 Nef via an SH3 related
domain in a two-hybrid assay as well as in a protein
binding assay and was strongly expressed in hematopo-
etic tissues.
RESULTS
The Nef proteins of divergent HIV-strains differ
in their binding properties for HCK
To determine if Nef proteins of highly divergent strains
of HIV interact with the same intracellular proteins we
analyzed the binding to HCK in a two-hybrid system.
While the interaction of HIV-1LAINef, which had been
described in vitro (Saksela et al., 1995) could be con-
firmed (Fig. 1A), no interaction was seen with the Nef
protein of a highly divergent subtype B HIV-2 strain,
HIV-2D205 (Dietrich et al., 1989). Figure 1B shows the
alignment of the Nef protein of HIV-1LAI and the corrected
sequence of HIV-2D205. The two proteins have a homol-
ogy of only 40%. Compared to HIV-1LAI the acidic region
and the proline-rich motif (boxed) are principally con-
served in HIV-2D205 but exhibit several substitutions. Es-
pecially a valine residue in the proline-rich motif (PQVP),
which is conserved in nearly all other Nef proteins, is
FIG. 1. Distinct Nef proteins differ in binding of HCK. (A) Interaction of Nef proteins with the protein tyrosine kinase HCK in the two-hybrid system:
(a) LexA-HIV-1LAINef 1 VP16, (b) LexA-HIV-1LAINef 1 VP16-HCK-SH3, (c) LexA-HIV-2D205Nef 1 VP16, (d) LexA-HIV-2D205Nef 1 VP16-HCK-SH3, (e)
LexA-daughterless 1 VP16, (f) LexA-daughterless 1 VP16-MyoD, (g) LexA-daughterless 1 VP16-HCK-SH3, (h) LexA 1 VP16, (i) LexA 1 VP16-HCK-
SH3. The L40 strain was transformed with two-hybrid plasmids and transformants were streaked on media lacking the indicated amino acids. Growth
on medium -His, -Trp, -Leu, 110 mM 3-AT selects for interaction of the fusion proteins. On medium Trp, -Leu as a control no interaction is selected.
The addition of 10 mM 3-aminotriazole is neccessary to supress the background activation of the LexA-Nef fusions with the isolated VP16 domain.
Only the positive control daughterless 1 MyoD (f, Hollenberg et al., 1995) as well as HIV-1LAI-Nef 1 HCK-SH3-domain (b) show an interaction, but
not HIV-2D205-Nef 1 HCK-SH3-domain (d). (B) Comparison of the Nef proteins of HIV-1LAI and HIV-2D205: Amino acid sequences of the Nef proteins
of HIV-1LAI and HIV-2D205 were aligned using the one letter code. Identical residues were replaced by dots and gaps introduced for optimal alignment
are shown as horizontal lines. Verification of our earlier described sequence (Kreutz et al., 1992) of the nef open reading frame of HIV-2D205 revealed
some discrepancies in the amino-terminal region of the protein. The corrected sequence is used here. The homology of the two proteins is 40% at
the amino acid level. Two functional motifs are boxed: The acidic stretch which is critical for CD4 downregulation and the proline-rich region, which
was shown to be involved in enhancement of viral infectivity (Goldsmith et al., 1995) and binds in vitro to the SH3 domain of the protein tyrosine kinase
HCK (Saksela et al., 1995). (C) Differences of subtypes and (D) mutational analysis of Nef binding to HCK: Two-hybrid constructs of the Nef proteins
from different HIV isolates and mutants are shown schematically. The locations of the acidic stretch and the proline-rich motif are represented by
boxes. The results of these constructs in two-hybrid interaction assays with the SH3 domain of human HCK are given on the right. For the
classification of strong or weak interactions see Materials and Methods.
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replaced by an arginine (PNRP) in HIV-2D205. In contrast
to HIV-2D205, the Nef protein of an HIV-1 subtype E isolate
(HIV-1HR004, Ruppach et al., 1996), displayed HCK binding
comparable to that of Nef of HIV-1LAI (Fig. 1C, construct
2), while the Nef protein of the HIV-2 subtype A isolate
HIV-2D194 (Ku¨hnel et al., 1989) only showed a weak inter-
action with the SH3 domain of HCK (construct 3, Fig. 1C).
To determine which parts of the molecules are es-
sential for a strong interaction, a mutational analysis
was carried out (Fig. 1D). The aminoterminal part of
HIV-1LAI-Nef is dispensable for a strong interaction
with HCK (construct 2). In case of HIV-2D205, both the
full length and the core domain of Nef lack the ability
to interact with HCK (constructs 3 and 4). A substitu-
tion of the proline-rich motif of HIV-2D205 (PNRP) by the
corresponding amino acids of HIV-1LAI (PQVP) re-
stores a weak interaction with HCK (construct 5), com-
parable to the signal of HIV-2D194 and to the signal of
a 10-amino-acid peptide containing this motif (con-
struct 6). Vice versa, the substitution of the PxxP motif
in HIV-1LAI Nef with that of HIV-2D205 totally abolished
binding to HCK (construct 7).
Thus neither HIV-2D194 Nef nor the HIV-2D205
PQVP mutant
protein resemble HIV-1LAI Nef in the property of interacting
strongly with HCK when expressed as full-length proteins.
Nevertheless the sequence of the PQVP motif of HIV-1LAI
Nef seems to be essential for the interaction with HCK,
since mutation of the QV doublet in HIV-1LAI Nef to the
corresponding NR doublet of the HIV-2D205 protein (PNRP)
totally abrogates the interaction (Fig. 1D, construct 7 com-
pared to construct 2).
Isolation of HIV-2D205-Nef interacting proteins
Since HIV-2D205 Nef differed in its binding properties
from HIV-1LAI Nef, we performed a two-hybrid screening
in order to isolate proteins which interact with HIV-2D205
Nef. A LexA-based two-hybrid system (Hollenberg et al.,
1995) with a size-selected cDNA library (Vojtek et al.,
1993; Hollenberg et al., 1995) was used for screening
with HIV-2D205 Nef as a bait. To simplify the screening
process, a URA3 marker was additionally introduced into
the bait plasmid (pBTM116) and a ura32 derivate of the
L40 strain was used. This addition to the system allows
an efficient counterselection against the bait plasmid
after short segregation, which reduces the work in veri-
fying the specifity of the isolated clones. Of 5 3 106
transformants plated on selection medium 16 specific
clones were obtained which represented six different
proteins based on sequence analysis.
To demonstrate direct interaction of the proteins,
binding experiments with the Nef protein of HIV-2D205
expressed in a baculovirus system and bacterially
expressed GST fusions of the potential binding part-
ners were performed. One protein was found to also
interact in vitro with HIV-2D205-Nef (see Fig. 3A). It
represents an unknown protein, which was isolated as
six independent clones and was named Nefin1 for
‘‘Nef interaction partner-1.’’ As expected, in contrast to
HIV-2D205 Nef, the Nef protein of HIV-1LAI did not in-
teract with Nefin1 in the two-hybrid system (data not
shown). This specifity corresponds to the result with
the HCK SH3 domain and confirms that the Nef pro-
teins of HIV-1LAI and HIV-2D205 differ in their binding
properties. Interestingly, even HIV-2D194 Nef did not
show an interaction with Nefin1.
Cloning of the complete cDNA of Nefin1
Since only a part of the open reading frame of Nefin1
was isolated in the two-hybrid screen a cDNA library
from human thymus was screened to obtain the full-
length sequence. Several rounds of screening led to
overlapping clones, which resulted in a combined se-
quence of 3.2 kb with an open reading frame encoding a
protein of 923 amino acids, as shown in Fig. 2A. A
database search using the Nefin1 sequence resulted in
no homology to known sequences, indicating that Nefin1
represents a novel protein. Nevertheless, the Nefin1 se-
quence displays several motifs possibly involved in pro-
tein–protein interactions: A putative leucine zipper is
located at amino acids 242 to 264, and 15 tyrosine res-
idues as possible binding sites for SH2 domains are
found throughout the protein as well as several PxxP
motifs, which could represent binding sites for SH3 do-
mains. The carboxy-terminal region (aa 829–900) of Ne-
fin1 is predicted to form a coiled coil (Lupas et al., 1991).
In addition, a potential bipartite nuclear localization se-
quence is found at aa 201–204 and 215–218.
The Nef binding region of Nefin1 is related
to SH3 domains
All six overlapping clones isolated in the two-hybrid
screen encompass a 72-amino-acid domain, which re-
sides in the amino-terminal region of Nefin1 (shaded in
Fig. 2A), limiting the Nef interaction domain to this region.
A more detailed analysis of this domain revealed a clear
relationship to SH3 domains. A comparison with several
SH3 domains is given in Fig. 2B.
Expression of Nefin1 in human and murine tissues
Northern blot analysis was performed to characterize the
mRNA expression of Nefin1. As shown in Fig. 2C a 4.4-kb
transcript was hybridized under high stringency with
poly(A)1 RNA from several murine (Fig. 2C, lanes a–h) and
human (Fig. 2C, lanes i–o) tissues. Particularly, lanes i–o in
Fig. 2C revealed a strong expression of Nefin1 mRNA in all
human hematopoetic tissues analyzed.
The proline-rich motif but not the acidic stretch of
HIV-2D205 Nef is necessary for interaction with Nefin1
Figure 3A shows the in vitro interaction of a GST
fusion protein of the Nef binding domain of Nefin1 with
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HIV-2D205 Nef expressed using a baculovirus system.
Since the Nef binding domain of Nefin1 is related to
SH3 domains, we next tested which region of the Nef
protein is responsible for the interaction with this
domain of Nefin1. Two-hybrid analyses of various de-
letion constructs of HIV-2D205 Nef (Fig. 3B) revealed
FIG. 2. Characterization of Nefin1. (A) Amino acid sequence of the full-length Nefin1 protein: The sequence is given using the one-letter code for
amino acids. The Nef binding domain is shaded and potential tyrosine phosphorylation sites are marked by dots. Putative SH3 binding sites are boxed
and the leucine zipper is shown by white letters on black boxes. A potential bipartite nuclear localization signal (aa 201–204/215–218) as well as a
predicted coiled coil region at the carboxyl terminus are underlined. (B) Relationship of the Nef binding domain of Nefin1 to SH3 domains: SH3
domains of various proteins were compared with the Nef binding domain of Nefin1 in a multiple sequence alignment using the CLUSTAL-W program
(Thompson et al., 1994). The region of Nefin1 which is sufficient for binding is marked by two arrows under the sequence. Above the alignment the
position of five b-sheets and loops according the crystal structure of the FYN SH3 domain (Noble et al., 1993) is schematically shown. Amino acid
residues are boxed if they are identical with the Nefin1 sequence or correspond to one of the following groups: hydrophobic (M/L/I/V/C), aromatic
or ring (F/Y/W/H), small near neutral (A/G/S/T/P), acidic or uncharged polar (D/E/N/Q), and basic (K/R/H). A tryptophane residue (W), which is
conserved in all domains, is shown inverted. (C) Expression of Nefin1 in human and murine tissues: Autoradiography of northern blots with different
tissues from mice (lanes a–h: heart, brain, spleen, lung, liver, skeletal muscle, kidney, and testis) or hematopoetic human tissues (lanes i–o: spleen,
lymph node, thymus, appendix, peripheral blood leukocyte, bone marrow, and fetal liver). Both blots were hybridized with single stranded DNA probes
of the murine and human Nefin1 respectively and washed under high stringency (0.1 3 SSC, 0.1% SDS, 60°C). Size markers in kb are given on the
left. Standardization of the blots using a GAPDH probe showed no signal in lane c (murine spleen).
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that removing the amino-terminal part of Nef including
the acidic stretch did not reduce the interaction with
Nefin1. In contrast, the deletion of the proline-rich
region completely abolished binding. Most carboxy-
terminal deletions of Nef also led to complete loss of
the interaction. Even a relatively short carboxy-termi-
nal truncation greatly reduced binding. In conclusion,
it appears that the interaction of HIV-2D205 Nef with the
novel protein is dependent on the core domain of Nef,
including the PxxP motif as with other nef interacting
proteins, and that noncontiguous regions in the pri-
mary structure influence the binding as shown for the
structures of the HIV-1BH10Nef * HCK SH3 complex
(Grzesiek et al., 1996) and the HIV-1NL4-3 * FYN
R96ISH3
complex (Lee et al., 1996). However, gross structural
disturbances due to the carboxy-terminal deletions can-
not be ruled out. Replacement of the proline-rich motif
(PNRP) of the Nef protein of HIV-2D205 with the corre-
sponding motif (PQVP) of HIV-1LAI greatly reduced the
interaction with Nefin1 in yeast; however, a residual
weak binding was still detectable.
DISCUSSION
In this report we provide evidence that the Nef
proteins from distinct HIV isolates are different with
respect to their association with cellular proteins. De-
spite the ability to confirm the interaction of the SH3
domain of human HCK with the Nef protein from the
HIV-1 isolate LAI in a cellular environment and to
demonstrate binding to the Nef protein of a subtype E
isolate of HIV-1, we were unable to detect this inter-
action using Nef from the divergent isolate HIV-2D205.
In addition, even the HIV-2 subtype A isolate HIV-2D194
showed only a weak interaction with HCK. Our mu-
tagenesis studies suggest that the inability of HIV-
2D205 Nef to bind HCK is due to a substitution of the
amino acid doublet QV in the proline-rich motif of
HIV-1LAI Nef (PQVP) to NR in HIV-2D205 (PNRP). Espe-
cially the valine residue, which is replaced by an
arginine, is highly conserved in nearly all Nef proteins
described in the Los Alamos HIV database. Interest-
ingly, HIV-2UC1, the most closely related HIV-2 strain to
HIV-2D205, displays an identical sequence in this re-
gion (Barnett et al., 1993). In the crystal structure of the
HIV-1NL4-3 Nef complexed with a mutated FYN
R961SH3
domain this valine residue is completely buried at the
interface owing to tertiary interactions of the Nef pro-
tein (Lee et al., 1996). Nevertheless, a mutation of this
sequence in HIV-2D205 to the corresponding sequence
of HIV-1LAI Nef results only in a weak interaction with
HCK comparable to the HIV-2 subtype A isolate HIV-
2D194, which is comparable to the interaction of the
proline-rich peptide only. In contrast, HIV-1LAI full-
length Nef protein shows a considerably stronger in-
teraction (see Fig. 1D and Lee et al., 1995). Thus the
C-terminal part of Nef also is important for a strong
interaction with cellular proteins.
Several other proteins have been described to show
interactions with different Nef isolates: b-COP, a compo-
nent of non-clathrin-coated vesicles, was isolated in a
two-hybrid screen with HIV-1LAI Nef (Benichou et al.,
1994) but interacts only weakly with HIV-2 isolates (R.
Benarous, personal communication). For LCK, contradic-
tory results were reported but novel data suggest a
possible complex of a serine kinase with LCK, which
binds to the amino terminus of Nef (Baur et al., 1997).
Considerable interest has been generated by a serine
kinase activity, which coprecipitates with Nef from
HIV-1SF2 (Sawai et al., 1994) as well as SIVmac239 (Sawai
et al., 1995) and phosphorylates a 62-kD protein. Recent
data suggest that p62 is the kinase itself and resembles
members of the PAK family (Nunn and Marsh, 1996). Very
importantly, the inability of mutant Nef to associate with
FIG. 3. Interaction of HIV-2D205 Nef with Nefin1. (A) In vitro interaction
of HIV-2D205 Nef with Nefin1: 1 mg purified GST (lanes 1 and 2) or
GST-Nefin1 (lanes 3 and 4) were either directly loaded (lanes 2 and 4)
or incubated with lysate of HIV-2D205-Nef expressing Sf9 cells (lanes 1
and 3) and subsequently resolved on SDS–PAGE. Nef protein recov-
ered from the lysate was detected by Western blotting using a Nef-
specific antibody. As a control, 20% of the Sf9 lysate used in the binding
assays was directly loaded in lane 5. (B) Two-hybrid interaction anal-
ysis of Nefin1 with deletion constructs of HIV-2D205 Nef: Several dele-
tion constructs of HIV-2D205 Nef as well as one mutated construct
containing a PQVP-motif are schematically shown. The locations of the
acidic stretch and the proline-rich motif are represented by boxes. The
results of two-hybrid interaction assays of the constructs with the Nef
binding domain of Nefin1 are given on the right. For scoring the
strength of the interaction see Materials and Methods.
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p62 seems to correlate with a reduced viral load in
monkeys (Sawai et al., 1996). However, recent data have
also shown that even in the case of this kinase the
association is dependent on the viral isolate (Luo and
Garcia, 1996) and in another study, interaction of cellular
serine/threonine kinases with Nef appeared dispensable
for the development of AIDS in rhesus monkeys (Lang et
al., 1997).
In this study we isolated Nefin1, a novel protein with
characteristics of an adaptor protein as an interaction
partner for the Nef protein of HIV-2D205. The interaction is
mediated by an SH3-related domain. However, Nefin1
did not show an interaction with the Nef proteins of
HIV-1LAI or the HIV-2 subtype A isolate HIV-2D194. In
conclusion, it thus appears that several cellular factors
associate with the Nef proteins of different HIV/SIV
strains and that the composition of these complexes may
differ between strains. Another possibility would be that
the interaction of Nef with tyrosine kinases would differ
between HIV-1 and SIV as well as HIV-2 by the usage of
different domains, e.g., SH3 versus SH2 as suggested by
Lang et al. (1997). If and how this influences the patho-
genicity of HIV and SIV remains to be determined.
MATERIALS AND METHODS
Two-hybrid system
For generation of pBTM116URA a 1-kb fragment of the
complete S. cerevisiae URA3 gene was amplified by PCR
and cloned into the PvuII site of the plasmid pBTM116
(Bartel et al., 1993). Nef sequences were amplified by
PCR using primers that introduce an EcoRI site at the 59
end and a SalI site at the 39 end. Subsequently the
fragments were cloned into the corresponding restriction
sites in plasmid pBTM116URA in frame with the Esche-
richia coli LexA DNA binding domain. Mutant proteins
were generated by site-directed mutagenesis
(QuikChange, Stratagene) according to the manufactur-
er’s instructions. For LexA peptide fusions sense and
antisense oligonucleotides with a 59 EcoRI and a 39 SalI
overhang were annealed and cloned into the corre-
sponding restriction sites of pBTM116. All clones were
verified by sequencing. A two-hybrid interaction was
scored positive when a streak of yeast containing a bait
paired with a VP16 fusion protein showed full growth at
a concentration of 3-aminotriazole at least two times
higher than the threshold concentration necessary for
total inhibition of growth when the bait was paired with
the isolated VP16 activation domain. Interactions that did
not meet this criterion were scored as weak. Pairings
that allowed growth at a 3-amino triazole concentration
at least 103 higher than that necessary to suppress
background with the isolated VP16 activation domain
were scored as strong interactions (symbolized by 11).
Two-hybrid screenings were performed essentially as
described (Vojtek et al., 1993) except that an ura32 de-
rivate of the L40 strain was used together with
pBTM116URA. To test the specifity of clones, segregation
was allowed on plates without leucine followed by a
counterselection on plates with 5-FOA (5-fluoroorotic
acid). The resulting ‘‘bait-cured’’ strains were again
grown on plates without leucine and retransformed in
96-well plates with Nef or unrelated bait constructs,
respectively. Library inserts from specific clones were
PCR amplified and directly sequenced.
cDNA cloning and sequence analysis
The nef open reading frame from an HIV subtype E
isolate was cloned by PCR from genomic DNA of periph-
eral blood mononuclear cells infected with HIV subtype E
(isolate HR004, Ruppach et al., 1996). Sequence deter-
mination of the open reading frame revealed a deduced
amino acid sequence corresponding to the consensus
sequence published (Artenstein et al., 1996). Isolation of
the full-length Nefin1 sequence was performed by stan-
dard cDNA library screening methods using PCR-gener-
ated probes as well as anchored and ligation mediated
PCR as described (Karn et al., 1993). Sequencing of
double-stranded DNA was done using an ABI 373A se-
quencer and the dye terminator chemistry according to
the protocols of the manufacturer (Applied Biosystems).
Sequence comparisons and analysis were performed
using the Microgenie software package (Beckmann) as
well as the FASTA (Pearson et al., 1988), CLUSTAL-W
(Thompson et al., 1994), and COILS (Lupas et al., 1991)
programs.
Northern blot analysis
Multiple tissue blots were purchased from Clontech
(Palo Alto, CA). A single-stranded cDNA probe corre-
sponding to aa 160 to 300 of Nefin1 was generated by
PCR using [a-32P]dCTP (6000 Ci/mmol) as described
(Karn et al., 1993). Hybridization was done using Quick-
Hyb-Solution (Stratagene) according to the manufactur-
er’s instructions.
In vitro binding studies
Positive clones from the two-hybrid screen were sub-
cloned as NotI fragments in pGEX-4T1 (Pharmacia) fol-
lowed by expression and purification of the resulting GST
fusion proteins in E. coli as described by the manufac-
turer. For expression in Sf-9 cells a cDNA containing the
complete open reading frame of a myristylation-deficient
version of HIV-2D205 Nef in the BamHI site of pAcYM1 (a
generous gift from D. Bishop) was used. Recombinant
baculoviruses expressing HIV-2D205 Nef were prepared
by homologous recombination of the plasmid with linear-
ized BaculoGold DNA (Pharmingen) according to the
manufacturer’s instructions. At 48 h postinfection the Sf-9
cells were washed twice in PBS and lysed with ice-cold
lysis buffer (20 mM Tris–Cl, pH 8.0, 150 mM NaCl, 1 mM
EDTA, 0.5% NP-40), freshly supplemented with 10 mg/ml
leupeptin and aprotinin, 1 mM phenylmethylsulfonyl fluo-
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ride. Cell lysates were prepared by freeze/thaw cycles
and clarified by centrifugation for 10 min at 12,000 g.
Protein concentrations were determined using the BCA
method (Pierce). Sf-9 cell extracts were incubated over-
night at 4°C with either GST or GST fusion proteins
coupled to glutathione Sepharose beads. After washing
with ice-cold lysis buffer the proteins were released from
the Sepharose by boiling 2 min in SDS sample buffer and
electrophoresed on a 12% SDS–polyacrylamide gel. After
protein transfer onto Immobilon-P (Millipore), the filters
were preincubated overnight with 5% dry milk in PBST
(0.05% Tween 20 in PBS) at 4°C, incubated 1 h with the
primary antibody at 22°C in reaction buffer (5% dry milk
in PBST), washed three times, and incubated for 1 h with
horseradish peroxidase-conjugated goat anti-mouse an-
tibody (Sigma). Immunoblots were developed using the
ECL system (Du Pont, NEN).
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